Clearmind Medicine (CMND) News
NASDAQ: CMNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
6.58-0.02 (-0.30%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 6.85 +4.08%
CMND news summary
We found 2 recent headlines mentioning Clearmind Medicine (CMND): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. For price context, CMND is down 0.30% at $6.58. The most recent story, "Clearmind Gains Japan Patent Coverage For 3-MMC And PEA Combination", was published by Nasdaq on Oct 8, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Clearmind Medicine headlines
- Clearmind Gains Japan Patent Coverage For 3-MMC And PEA Combination(RTTNews) - Clearmind Medicine (CMND) announced the publication in Japan of a patent application covering novel compositions and methods for treating dyskinesia, a neurological movement disorder…NasdaqCMND, BRK.B
- Clearmind Announces Patent Publication in Japan Covering Treatment for Neurological Movement DisorderPublished patent application covers 3-MMC-based treatment of dyskinesia, including in combination with Palmitoylethanolamide (PEA)GlobeNewswire